Dr. Khalid Kakish, MD

NPI: 1093009680
Total Payments
$401.57
2024 Payments
$236.05
Companies
8
Transactions
12

Payment Breakdown by Category

Food & Beverage$396.83 (98.8%)
Education$4.74 (1.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $396.83 11 98.8%
Education $4.74 1 1.2%

Top Paying Companies

Company Total Records Latest Year
Pyros Pharmaceuticals, Inc. $206.89 2 $0 (2024)
LivaNova USA, Inc. $60.76 3 $0 (2019)
Neurelis, Inc. $35.76 2 $0 (2021)
UCB, Inc. $29.16 1 $0 (2024)
SK Life Science, Inc. $22.72 1 $0 (2023)
Biocodex, Inc. $21.55 1 $0 (2023)
BioMarin Pharmaceutical Inc. $19.99 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $236.05 3 Pyros Pharmaceuticals, Inc. ($206.89)
2023 $44.27 2 SK Life Science, Inc. ($22.72)
2021 $35.76 2 Neurelis, Inc. ($35.76)
2019 $58.30 3 LivaNova USA, Inc. ($38.31)
2018 $27.19 2 LivaNova USA, Inc. ($22.45)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/19/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $29.16 General
Category: Neurology
09/19/2024 Pyros Pharmaceuticals, Inc. VIGPODER (Drug) Food and Beverage In-kind items and services $189.56 General
Category: PEDIATRIC NEUROLOGY
09/19/2024 Pyros Pharmaceuticals, Inc. VIGPODER (Drug) Food and Beverage In-kind items and services $17.33 General
Category: PEDIATRIC NEUROLOGY
11/20/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $21.55 General
Category: Antiepileptic
04/26/2023 SK Life Science, Inc. Food and Beverage In-kind items and services $22.72 General
10/19/2021 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $19.54 General
Category: EPILEPSY
05/26/2021 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $16.22 General
Category: EPILEPSY
09/05/2019 LivaNova USA, Inc. VNS Therapy (Device) Food and Beverage In-kind items and services $19.47 General
Category: Cardiology/Vascular Diseases
06/13/2019 LivaNova USA, Inc. VNS Therapy (Device) Food and Beverage In-kind items and services $18.84 General
Category: Cardiology/Vascular Diseases
02/14/2019 BioMarin Pharmaceutical Inc. Vimizim (Biological), Naglazyme, Brineura Food and Beverage In-kind items and services $19.99 General
Category: MPS IVA
10/11/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $4.74 General
Category: Hepatology
03/19/2018 LivaNova USA, Inc. VNS Therapy (Device) Food and Beverage In-kind items and services $22.45 General
Category: VNS Therapy (Product Class)

About Dr. Khalid Kakish, MD

Dr. Khalid Kakish, MD is a Pediatrics healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1093009680.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Kakish, MD has received a total of $401.57 in payments from pharmaceutical and medical device companies, with $236.05 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($396.83).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Neurology, Neurology with Special Qualifications in Child Neurology
  • Location Buffalo, NY
  • Active Since 06/01/2011
  • Last Updated 11/09/2016
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1093009680

Products in Payments

  • VIGPODER (Drug) $206.89
  • VNS Therapy (Device) $60.76
  • VALTOCO (Drug) $35.76
  • Fintepla (Drug) $29.16
  • DIACOMIT (Drug) $21.55
  • Vimizim (Biological) $19.99
  • (820) Cholbam (Drug) $4.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Buffalo